News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Collins James J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/29/2023 |
4
| Collins James J. (Director) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.16, valued at
$94.8k
|
|
| 05/18/2023 |
4
| Collins James J. (Director) has filed a Form 4 on Orion Biotech Opportunities Corp.|
Txns:
| Disposed/sold 40,000 options to buy
@ $0 |
|
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Collins James J. (Director) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Granted 9,285 options to buy
@ $17.63, valued at
$163.7k
|
|
| 07/18/2019 |
4
| Collins James J. (Director) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Granted 5,714 options to buy
@ $16, valued at
$91.4k
|
|
|
|